Dapagliflozin attenuates ferroptosis in diabetic nephropathy through activation of the Nrf2/HO‑1 signaling pathway
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5842 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Hanshuang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, P.R. China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Diabetic Nephropathies, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Renal tubular injury has emerged as a critical determinant in the pathogenesis of diabetic nephropathy (DN). Ferroptosis, a recently characterized mode of iron‑dependent regulated cell death, has been implicated in the development of renal tubular damage. Dapagliflozin (DAPA), a sodium‑glucose cotransporter 2 inhibitor, has demonstrated efficacy in attenuating DN progression and preserving renal function. The present study sought to elucidate the inhibitory mechanisms by which DAPA modulates ferroptosis in DN. To this aim, the expression profiles of key molecular markers within the ferroptosis cascade were systematically evaluated using 6‑week‑old male C57BL/6J mice and high‑glucose‑cultured human renal tubular epithelial cells as experimental models. The findings revealed that DAPA notably ameliorated renal histopathological alterations, upregulated the expression of solute carrier family 7 member 11, glutathione peroxidase 4 and ferritin heavy chain 1, whilst concomitantly downregulating transferrin receptor 1. These effects were mediated through the activation of nuclear factor erythroid 2‑related factor 2 (Nrf2) and heme oxygenase‑1 (HO‑1) in C57BL/6J mice. Collectively, these data indicate that the reno‑protective effects of DAPA in DN may be attributable to the suppression of ferroptosis via activation of the Nrf2/HO‑1 signaling axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, P.R. China.
- Department of Endocrinology, The Second Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, P.R. China.
Zitieren
APA
Liu, H., Zhang, X., Cui, Y., Xiong, S., Huang, L., Li, M., Shao, C., & Hu, X. (2026). Dapagliflozin attenuates ferroptosis in diabetic nephropathy through activation of the Nrf2/HO‑1 signaling pathway. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5842
Vancouver
Liu H, Zhang X, Cui Y, Xiong S, Huang L, Li M, et al. Dapagliflozin attenuates ferroptosis in diabetic nephropathy through activation of the Nrf2/HO‑1 signaling pathway. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5842
BibTeX
@article{Liu2026,
author = {Liu, Hanshuang and Zhang, Xiaoxiao and Cui, Yubing and Xiong, Shengxi and Huang, Linjuan and Li, Min and Shao, Chen and Hu, Xiaolei},
title = {Dapagliflozin attenuates ferroptosis in diabetic nephropathy through activation of the Nrf2/HO‑1 signaling pathway},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5842}
}
EUVIMED